Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Shanks

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|August 25, 1973
Mexiletine (Kö 1173) in the management of ventricular dysrhythmiasN P Campbell, J G Kelly, R G Shanks, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited eliminationH W Van den Berg, Z R Desai, R Wilson, et al.
Postgraduate Medical Journal|January 1, 1977
The development of mexiletine in the management of ventricular dysrhythmiasN P Campbell, N C Chaturvedi, R G Shanks, et al.
British Journal of Clinical Pharmacology|March 1, 1986
Dose independent pharmacokinetics of mexiletine in healthy volunteersT Pringle, J Fox, J A McNeill, et al.
British Journal of Clinical Pharmacology|May 1, 1985
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in manJ M Arnold, P C O'Connor, J G Riddell, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteersP C O'Connor, M J Finch, D W Harron, et al.
Lancet (London, England)|December 20, 1980
Oral mexiletine in high-risk patients after myocardial infarctionD A Chamberlain, D E Jewitt, D G Julian, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|August 28, 2024
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometryJoseph Kennedy, Kevin G Shanks, Kristine Van Natta, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The duration of effect of SL75212 on an exercise tachycardia [proceedings]K Balnave, J D Neill, C J Russell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 1999
Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetablesA J McEligot, C L Rock, T G Shanks, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|August 25, 1973
Mexiletine (Kö 1173) in the management of ventricular dysrhythmiasN P Campbell, J G Kelly, R G Shanks, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited eliminationH W Van den Berg, Z R Desai, R Wilson, et al.
Postgraduate Medical Journal|January 1, 1977
The development of mexiletine in the management of ventricular dysrhythmiasN P Campbell, N C Chaturvedi, R G Shanks, et al.
British Journal of Clinical Pharmacology|March 1, 1986
Dose independent pharmacokinetics of mexiletine in healthy volunteersT Pringle, J Fox, J A McNeill, et al.
British Journal of Clinical Pharmacology|May 1, 1985
Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in manJ M Arnold, P C O'Connor, J G Riddell, et al.
British Journal of Clinical Pharmacology|December 1, 1985
Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteersP C O'Connor, M J Finch, D W Harron, et al.
Lancet (London, England)|December 20, 1980
Oral mexiletine in high-risk patients after myocardial infarctionD A Chamberlain, D E Jewitt, D G Julian, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|August 28, 2024
Rapid screening and identification of novel psychoactive substances using PaperSpray interfaced to high resolution mass spectrometryJoseph Kennedy, Kevin G Shanks, Kristine Van Natta, et al.
British Journal of Clinical Pharmacology|March 1, 1980
The duration of effect of SL75212 on an exercise tachycardia [proceedings]K Balnave, J D Neill, C J Russell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 1999
Comparison of serum carotenoid responses between women consuming vegetable juice and women consuming raw or cooked vegetablesA J McEligot, C L Rock, T G Shanks, et al.
Pageof 21